Cargando…

Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease

There is much interest in the use of mesenchymal stem cells/marrow stromal cells (MSC) to treat neurodegenerative disorders, in particular those that are fatal and difficult to treat, such as Huntington’s disease. MSC present a promising tool for cell therapy and are currently being tested in FDA-ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olson, Scott D., Pollock, Kari, Kambal, Amal, Cary, Whitney, Mitchell, Gaela-Marie, Tempkin, Jeremy, Stewart, Heather, McGee, Jeannine, Bauer, Gerhard, Kim, Hyun Sook, Tempkin, Teresa, Wheelock, Vicki, Annett, Geralyn, Dunbar, Gary, Nolta, Jan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Humana Press Inc 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259334/ https://www.ncbi.nlm.nih.gov/pubmed/22161544 http://dx.doi.org/10.1007/s12035-011-8219-8

Ejemplares similares

Developing stem cell therapies for juvenile and adult-onset Huntington’s disease
por: Fink, Kyle D, et al.
Publicado: (2015)

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
por: Pollock, Kari, et al.
Publicado: (2016)

Contribution of human hematopoietic stem cells to liver repair
por: Zhou, Ping, et al.
Publicado: (2009)

Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
por: Deng, Peter, et al.
Publicado: (2016)

A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
por: Dahlenburg, Heather, et al.
Publicado: (2021)

An immune deficient mouse model for mucopolysaccharidosis IIIA (Sanfilippo syndrome)
por: Pollock, Kari, et al.
Publicado: (2023)

Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2016)

PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder
por: Biswas, Dayita, et al.
Publicado: (2020)

Rehabilitation in a rural setting of a young quadriplegic accident victim. Integrative clinicopathological conference: medical, psychosocial, economic, preventive, and ethical dimensions of a case study.
por: Lewis, B. R., et al.
Publicado: (1985)

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
por: Beegle, Julie R, et al.
Publicado: (2016)

A quantitative map of nuclear pore assembly reveals two distinct mechanisms
por: Otsuka, Shotaro, et al.
Publicado: (2023)

Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2020)

Analysis of the retinal capillary plexus layers in a murine model with diabetic retinopathy: effect of intravitreal injection of human CD34(+) bone marrow stem cells
por: Cheung, Kong Wa, et al.
Publicado: (2021)

Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder
por: Rosser, Anne E., et al.
Publicado: (2022)

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014)

Stable low prevalence of Huntington’s disease in Finland
por: Sipilä, Jussi O.T., et al.
Publicado: (2023)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

HTT haplogroups in Finnish patients with Huntington disease
por: Ylönen, Susanna, et al.
Publicado: (2019)

N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease
por: Wright, D J, et al.
Publicado: (2015)

Comorbid epilepsy in Finnish patients with adult-onset Huntington’s disease
por: Sipilä, Jussi O. T., et al.
Publicado: (2016)

Dynamic molecular mechanism of the nuclear pore complex permeability barrier
por: Kozai, Toshiya, et al.
Publicado: (2023)

Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration
por: Park, Un Chul, et al.
Publicado: (2021)

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017)

Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor
por: Sheu, Jonathan, et al.
Publicado: (2015)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
por: Moll, Guido, et al.
Publicado: (2022)

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease
por: Dunbar, Gary L., et al.
Publicado: (2019)

Enfermedad de Huntington
por: Muñoz García, Esteban
Publicado: (1996)

Archer Milton Huntington
por: Gilman Proske, Beatrice, 1899-
Publicado: (1963)

Neuropsychiatry of Huntington's disease
por: Rosenblatt, Adam
Publicado: (2007)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

The History of Huntington's Chorea
por: Stevens, David L.
Publicado: (1972)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Huntington’s and the History of Sleep
por: Wexler, Alice R.
Publicado: (2023)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
por: Corrêa, Bernardo Barahona, et al.
Publicado: (2006)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
por: Hofer, Sebastian, et al.
Publicado: (2018)

Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion
por: Yuan, Oliver, et al.
Publicado: (2019)

The Journey to Sustainable Participation in Physical Activity for Adolescents Living with Cerebral Palsy
por: Kilgour, Gaela, et al.
Publicado: (2023)

Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
por: Fukuoka, Masashi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6soknncnl007eeg1bjkkkund0c